Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma

Human Pathology

Volumn 33, Issue 2, 2002, Pages 146-152

  Agarwal, Sandhya ^a   Ramanathan, Uma ^a   Naresh, Kikkerj N ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

ALK; Anaplastic large cell lymphoma; Epstein Barr virus; Lymphoma

Indexed keywords

CHIMERIC PROTEIN; GENE PRODUCT; LATENT MEMBRANE PROTEIN 1; PROTEIN ALK; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME TRANSLOCATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; T LYMPHOCYTE;

EID: 0036213906     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.31925     Document Type: Article

References (38)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma
3. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes)
4. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity
5. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
6. t(1;2)(q21;p23) and t(2;3) (p23;q21): Two novel variant translocations of the t(2;5) (p23;q35) in anaplastic large cell lymphoma
7. Lymphomas expressing ALK fusion protein(s) other than NPM
8. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 Cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
9. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage
10. Epstein-Barr viral DNA in tissues of Hodgkin's disease
11. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma
12. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas
13. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas
14. Epstein-Barr virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype
15. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas
16. CD30-positive anaplastic large cell lymphoma in childhood: Expression of p80npm/alk and absence of Epstein-Barr virus
17. Nodal cytotoxic lymphoma spectrum: A clinicopathologic study of 66 patients
18. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells
19. Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries
20. Epidemiology of EBV and Hodgkin's lymphoma
21. Distribution of various subtypes of non-Hodgkin's lymphoma in India: A study of 2773 lymphomas using R.E.A.L. and WHO Classifications
22. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK 1
23. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
24. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity
25. ALK(+) lymphoma: Clinicopathological findings and outcome
26. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
27. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2) (q25;p23) translocation
28. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations
29. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
30. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma
31. Lymphomas expressing ALK fusion protein (s) other than NPM-ALK
32. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
33. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review
34. Complement receptor type two (CR2, CR21): A target for influencing the humoral immune response and antigen-trapping
35. Epstein-Barr virus transformation: Involvement of latent membrane protein1-mediated activation of NF-kappaB
36. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells
37. Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells
38. Differential expression of bcl-2 family proteins in alk-positive and alk-negative anaplastic large cell lymphoma of t/null-cell lineage